Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance

Journal of Neuroscience

Volumn 20, Issue 18, 2000, Pages 7074-7079

  Vanderah, Todd W ^a   Gardell, Luis R ^a   Burgess, Shannon E ^a   Ibrahim, Mohab ^a   Dogrul, Ahmet ^a   Zhong, Cheng Min ^a   Zhang, En Tan ^a   Malan Jr , T Philip ^a   Ossipov, Michael H ^a   Lai, Josephine ^a   Porreca, Frank ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Abnormal pain; Dynorphin; Dynorphin antiserum; Morphine tolerance; Spinal; opioid receptors

Indexed keywords

DYNORPHIN; DYNORPHIN A; DYNORPHIN ANTIBODY; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; SODIUM CHLORIDE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG TOLERANCE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; NERVE INJURY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN;

EID: 0034666274     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-18-07074.2000     Document Type: Article

References (42)

1. Hyperalgesic response in a patient receiving high concentrations of spinal morphine
2. Dynorphin A increases Substance P release from trigeminal primary afferent C-fibers
3. Clinical experience of long-term treatment with epidural and intrathecal opioids - A nationwide survey
4. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: Restoration by MK-801 or dynorphin antiserum
5. Quantitative assessment of tactile allodynia in the rat paw
6. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat
7. Ultrastructural analysis of dynorphin B-immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the rat
8. Effect of dynorphin on ICGRP release from capsaicin-sensitive fibers
9. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine
10. Hyperalgesia induced by high-dose intrathecal sufentanil in neuropathic pain
11. Efficient analysis of experimental observations
12. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation
13. Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury
14. Activity-dependent neuronal plasticity following tissue injury and inflammation
15. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy
16. Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model
17. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn
18. NMDA-receptor regulation of substance P release from primary afferent nociceptors
19. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats
20. Continuous co-administration of dextromethorphan or MK-801 with morphine: Attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance
21. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C
22. Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
23. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions
24. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine
25. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A(1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy
26. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury
27. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
28. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury
29. Effect of chronic treatment with morphine, midazolam and both together on dynorphin(1-13) levels in the rat
30. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia
31. Paradoxical pain following high-dose spinal morphine
32. High-affinity interaction of (des-tyrosyl)dynorphin A(2-17) with NMDA receptors
33. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614
34. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: Assessment of opioid receptor changes
35. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
36. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats
37. Intrathecal high dose morphine produces hyperalgesia in the rat
38. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine
39. Chronic catheterization of the spinal sub-arachnoid space
40. High dose of spinal morphine produces a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications